Sökning: onr:"swepub:oai:gup.ub.gu.se/242057" >
Intravenous Use of ...
Intravenous Use of Prescription Psychostimulants; A Comparison of the Pattern and Subjective Experience between Different Methylphenidate Preparations, Amphetamine and Cocaine
-
Bjarnadottir, G. D. (författare)
-
Magnusson, A. (författare)
-
Rafnar, B. O. (författare)
-
visa fler...
-
Sigurdsson, E. (författare)
-
- Steingrimsson, Steinn (författare)
- Gothenburg University,Göteborgs universitet,Centrum för etik, juridik och mental hälsa,Centre for Ethics, Law, and Mental Health
-
Johannsson, M. (författare)
-
Bragadottir, H. (författare)
-
Haraldsson, H. M. (författare)
-
visa färre...
-
(creator_code:org_t)
- 2016-06-09
- 2016
- Engelska.
-
Ingår i: European Addiction Research. - : S. Karger AG. - 1022-6877 .- 1421-9891. ; 22:5, s. 259-267
- Relaterad länk:
-
https://gup.ub.gu.se...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background/Aims: Methylphenidate (MPH) has been the most commonly used intravenous (i.v.) substance in Iceland in recent years. In Iceland, MPH is available in 3 forms: immediate-release (IR) tablets (MPH IR, short-acting), sustainable-release (SR) capsules (MPH SR, long-acting) and osmotic-release (OROS) tablets (MPH OROS, long-acting). The aims of the study were to compare the pattern and subjective effects of i.v. MPH use to other i.v. psychostimulants and examine whether the pattern of use differs among MPH preparations. Methods: This is a nationwide descriptive study. Information was collected from 95 i.v. substance users undergoing inpatient detoxification and reporting i.v. MPH use in the last 30 days using a semi-structured interview. Results: MPH SR was both the most commonly used (96%) and preferred i.v. psychostimulant (57%). The intensity and duration of 'euphoria' did not differ between cocaine and MPH SR. No participant reported MPH OROS as their preferred substance even though a third had used it in the past month. Conclusions: The pattern of i.v. MPH use is similar to other psychostimulants among treatment seeking patients. MPH OROS was the least preferred i.v. psychostimulant, despite having the largest market share in Iceland. The results indicate that MPH OROS has less abuse potential than other MPH preparations. (C) 2016 S. Karger AG, Basel
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine (hsv//eng)
Nyckelord
- Methylphenidate
- Intravenous use
- Euphoria
- Injection rate
- Psychostimulants
- human brain
- dopamine transporters
- oral methylphenidate
- abuse
- humans
- adhd
- pharmacokinetics
- medications
- population
- stimulants
- Substance Abuse
- Psychiatry
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas